These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29224681)

  • 1. Role of interferons in SLE.
    Bengtsson AA; Rönnblom L
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):415-428. PubMed ID: 29224681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause and consequences of the activated type I interferon system in SLE.
    Eloranta ML; Rönnblom L
    J Mol Med (Berl); 2016 Oct; 94(10):1103-1110. PubMed ID: 27094810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
    Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
    Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside.
    Sim TM; Ong SJ; Mak A; Tay SH
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural interferon-alpha producing cells in systemic lupus erythematosus.
    Rönnblom L; Alm GV
    Hum Immunol; 2002 Dec; 63(12):1181-93. PubMed ID: 12480262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytokine network type I IFN-IL-27-IL-10 is augmented in murine and human lupus.
    Lee MH; Gallo PM; Hooper KM; Corradetti C; Ganea D; Caricchio R; Gallucci S
    J Leukoc Biol; 2019 Oct; 106(4):967-975. PubMed ID: 31216373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The innate immune system in SLE: type I interferons and dendritic cells.
    Rönnblom L; Pascual V
    Lupus; 2008 May; 17(5):394-9. PubMed ID: 18490415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.
    Mangini AJ; Lafyatis R; Van Seventer JM
    Ann N Y Acad Sci; 2007 Jun; 1108():11-23. PubMed ID: 17893966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity.
    Rönnblom L; Eloranta ML; Alm GV
    Autoimmunity; 2003 Dec; 36(8):463-72. PubMed ID: 14984023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus.
    Hamilton JA; Hsu HC; Mountz JD
    Discov Med; 2018 Jan; 25(135):21-29. PubMed ID: 29466691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J; Pascual V
    Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells.
    Li J; Ding H; Meng Y; Li G; Fu Q; Guo Q; Yin Z; Ye Z; Zhou H; Shen N
    Arthritis Rheumatol; 2020 Dec; 72(12):2106-2117. PubMed ID: 32608557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.